CRICCA, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 4.494
EU - Europa 3.684
AS - Asia 1.910
AF - Africa 224
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 10.328
Nazione #
US - Stati Uniti d'America 4.469
GB - Regno Unito 861
IT - Italia 819
CN - Cina 690
SE - Svezia 491
SG - Singapore 490
DE - Germania 428
VN - Vietnam 427
UA - Ucraina 298
IN - India 182
FR - Francia 164
IE - Irlanda 148
RU - Federazione Russa 142
CH - Svizzera 79
TG - Togo 72
BG - Bulgaria 67
ZA - Sudafrica 65
EE - Estonia 57
FI - Finlandia 42
CI - Costa d'Avorio 40
BE - Belgio 29
JO - Giordania 25
NG - Nigeria 23
JP - Giappone 22
SC - Seychelles 22
ID - Indonesia 21
IR - Iran 21
CA - Canada 19
GR - Grecia 12
NL - Olanda 10
UZ - Uzbekistan 9
DK - Danimarca 6
RO - Romania 6
AT - Austria 5
TR - Turchia 5
BR - Brasile 4
HK - Hong Kong 4
HR - Croazia 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
AU - Australia 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
PL - Polonia 3
CL - Cile 2
EC - Ecuador 2
ET - Etiopia 2
EU - Europa 2
MX - Messico 2
PE - Perù 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
PR - Porto Rico 1
SM - San Marino 1
Totale 10.328
Città #
Southend 742
Chandler 531
Singapore 435
Ashburn 428
Fairfield 380
Dong Ket 344
Houston 208
Woodbridge 205
Jacksonville 204
Wilmington 203
Princeton 192
Ann Arbor 188
Seattle 181
Santa Clara 170
Bologna 164
Dublin 148
Boardman 144
Cambridge 126
Westminster 84
Padova 77
Lomé 72
Bern 70
Nanjing 70
Berlin 67
Sofia 67
New York 60
Milan 59
Beijing 51
Medford 49
Saint Petersburg 45
Redwood City 41
Abidjan 40
Turin 40
Jinan 39
Mülheim 38
Shenyang 36
Helsinki 35
Redmond 34
Brussels 29
Florence 28
Nanchang 28
Chicago 27
Tianjin 27
Hebei 26
San Diego 26
Amman 25
Rimini 25
Zhengzhou 24
Abeokuta 23
Changsha 23
Bremen 22
Mahé 22
Jakarta 21
Guangzhou 20
Tokyo 19
Paris 18
Des Moines 17
Hangzhou 17
Shanghai 17
Los Angeles 16
Rome 15
Jiaxing 14
Kuban 14
Taizhou 14
Taiyuan 13
Treviso 13
Naples 12
Olalla 12
Verona 12
Falls Church 11
Haikou 11
Ningbo 11
Norwalk 11
Kunming 10
Shenzhen 9
Ardabil 8
San Venanzo 8
Shijiazhuang 8
Toronto 8
Wuhan 8
Lanzhou 7
Lappeenranta 7
Leawood 7
Phoenix 7
Washington 7
Bühl 6
Cesena 6
Dearborn 6
Monmouth Junction 6
Mountain View 6
Napoli 6
Xi'an 6
Chengdu 5
Copenhagen 5
Foshan 5
Genoa 5
Modena 5
Pune 5
Reggio Emilia 5
Udine 5
Totale 6.906
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 186
Evolution of cancer stem-like cells in endocrine-resistant metastatic breast cancers is mediated by stromal microvesicles 183
Abstract LB-236: Self-renewal of CD133hi cells by IL6/Notch3 signaling regulates endocrine resistance in metastatic breast cancers 174
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study 164
Mitochondrial DNA Mutation in Serous Ovarian Cancer: Implications for Mitochondria-Coded Genes in Chemoresistance 155
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 155
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 155
Exosome-based immunomodulation during aging: a nano-perspective on inflamm-aging 155
Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting 154
Comparison of the antibacterial activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine. A disk diffusion test 152
Carbonic anhydrase 9 mRNA/microRNA34a interplay in hypoxic human mammospheres 150
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 149
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 143
Analysis of HPV16 E6*I-II transcripts in cervical samples 141
Liquid biopsy in the diagnosis of HPV DNA in breast lesions 135
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 134
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 134
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 134
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 128
Papillomavirus associated malignancies in dogs and cats 128
HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles 128
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 126
DNA VIRAL INFECTIONS ASSAY IN KIDNEY TRANSPLANT RECIPIENTS BY A NEW HIGH THROUGHPUT MASS SPECTROMETRY METHOD 126
Occurrence of Albifimbria verrucaria in the Blood of a Female Child With Neuroblastoma 126
Staphylococcus aureus from goat to vets! 126
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 125
Recurrent erythema in patients with long-term parvovirus B19 infection 124
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 123
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 123
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 122
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 122
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 122
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 120
null 120
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 118
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 118
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer 117
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 115
Diffuse primary cutaneous infection by Alternaria alternata in a liver transplant recipient with pulmonary nocardiosis: Importance of prompt identification for clinical resolution 114
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 113
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 111
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 111
APPROCCIO MOLECOLARE NELLA DIAGNOSI RAPIDA DI ASPERGILLOSI INVASIVA: CONFRONTO CON LE METODICHE TRADIZIONALI 111
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 110
Human papillomavirus infection and pathogenic mitochondrial DNA mutation in bilateral multinodular oncocytic hyperplasia of the parotid 110
Sviluppo di un saggio di spettrometria di massa, ad elevata processività, per la ricerca e genotipizzazione di 12 HPV ad alto rischio oncogeno 108
Vemurafenib mucosal side-effect. 107
High-throughput genotyping of high-risk Human Papillomavirus by MALDI-TOF Mass Spectrometry-based method. 107
Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme 105
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 104
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 102
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study. 101
Lo studio PATER: Population-Based Frequency Assessment of HPV Infections in Borderline Pap Tests in the Emilia-Romagna Region 100
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 99
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 98
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 98
Metabolic profiling of Candida clinical isolates of different species and infection sources 97
High-throughput type-specific detection of HPV using MassARRAY technology 96
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 94
Detection of human Papilloma virus DNA in a subset of glioblastoma samples 94
DNA damage response (DDR) and senescence: shuttled inflamma-miRNAs on the stage of inflamm-aging 94
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 93
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 93
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 92
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature 92
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: A case report 91
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 90
Diagnosi virologica di infezione da papillomavirus umani 88
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 88
Implicazioni nella progressione della patologia cervicale 88
Epidemiologic case investigation on the zoonotic transmission of Staphylococcus aureus infection from goat to veterinarians 87
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 86
Total integration of cultural and molecular testing for CPE screening with liquid based microbiology (LBM) 86
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 84
Comparative evaluation of two colistin susceptibility-testing methods 84
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 83
valutazione quantitativa dell’attività antibatterica di coatings specifici applicati a supporti ceramici. 78
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 77
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 75
Are the Organoid Models an Invaluable Contribution to ZIKA Virus Research? 75
Rapid and sensitive detection of MS2 coliphages in wastewater samples by quantitative reverse transcriptase PCR 74
Construction and functional analysis of B19 genomic clones 73
Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions 69
Investigation on the presence of B19 virus prototype and variant genotypes in a population of italian blood donors 67
Investigation on the presence of B19 virus prototype and variant genotypes in a population of italian blood donors by a multiplex PCR assay 62
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 62
Persistenza di HR-HPV e CIN ricorrenti in donne conizzate per diagnosi di cervicocarcinoma microinvasivo 61
Quantitative two-step real time PCR based on LNA probes to detect HR HPV with different risk of oncogenic progression. 60
IDENTIFICAZIONE DIRETTA DI LIEVITI DA EMOCOLTURE POSITIVE CON METODICA SEPSITYPER 58
Molecular Approach for the Laboratory Diagnosis of Periprosthetic Joint Infections 56
Viral Population Heterogeneity and Fluctuating Mutational Pattern during a Persistent SARS‐CoV‐2 Infection in an Immunocompromised Patient 55
Indicatori molecolari di infezione da HPV 16 in lesioni cervicali di diverso grado 55
Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature 55
Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients 54
Host-Pathogen Interactions: Organotypic Cultures to Unravel the Mysteries of the Primordial Hostility among Organisms 53
Infezione da HPV e lesioni associate: screening in donne HIV-sieropositive 52
Evaluation of Biofilm Production and Antifungal Susceptibility to Fluconazole in Clinical Isolates of Candida spp. in Both Planktonic and Biofilm Form 47
Evaluation of a rapid Loop Mediated Isothermal Amplification (LAMP) test for the laboratory diagnosis of sexually transmitted infections 44
Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer 39
Analisi tramite spettroscopia infrarossi con trasformata di Fourier di ceppi di Streptococcus agalactiae isolati da uomo e bovino 32
Totale 10.352
Categoria #
all - tutte 28.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.161 0 0 0 0 0 159 189 236 226 151 89 111
2020/20211.665 285 119 56 68 66 98 44 80 149 87 82 531
2021/20221.919 136 94 105 164 182 96 32 116 91 249 343 311
2022/20232.140 215 290 107 248 160 142 71 132 359 64 204 148
2023/2024896 52 115 35 104 56 163 154 53 23 45 51 45
2024/20251.352 104 333 281 202 344 88 0 0 0 0 0 0
Totale 10.686